Last update 10 May 2025

US20240336562

Patent Mining

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
NLRP3
Action
inhibitors
Mechanism
NLRP3 inhibitors(NACHT, LRR and PYD domains-containing protein 3 inhibitors)
Therapeutic Areas
NeoplasmsImmune System DiseasesInfectious Diseases+ [9]
Active Indication
Cardiovascular DiseasesImmune System DiseasesInfectious Diseases+ [9]
Inactive Indication-
Originator Organization
Hangzhou Innogate Pharma Co., LtdHangzhou Innogate Pharma Co., Ltd
Active Organization
Hangzhou Innogate Pharma Co., LtdHangzhou Innogate Pharma Co., Ltd
Inactive Organization-
License Organization-
Drug Highest PhaseDiscovery
First Approval Date-
Regulation-

Related

100 Clinical Results associated with US20240336562
Login to view more data
100 Translational Medicine associated with US20240336562
Login to view more data
100 Patents (Medical) associated with US20240336562
Login to view more data
100 Deals associated with US20240336562
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Cardiovascular DiseasesDiscovery-
Hangzhou Innogate Pharma Co., LtdHangzhou Innogate Pharma Co., Ltd
10 Oct 2024
Immune System DiseasesDiscovery-
Hangzhou Innogate Pharma Co., LtdHangzhou Innogate Pharma Co., Ltd
10 Oct 2024
Infectious DiseasesDiscovery-
Hangzhou Innogate Pharma Co., LtdHangzhou Innogate Pharma Co., Ltd
10 Oct 2024
Kidney DiseasesDiscovery-
Hangzhou Innogate Pharma Co., LtdHangzhou Innogate Pharma Co., Ltd
10 Oct 2024
Liver DiseasesDiscovery-
Hangzhou Innogate Pharma Co., LtdHangzhou Innogate Pharma Co., Ltd
10 Oct 2024
Lymphatic DiseasesDiscovery-
Hangzhou Innogate Pharma Co., LtdHangzhou Innogate Pharma Co., Ltd
10 Oct 2024
Metabolic DiseasesDiscovery-
Hangzhou Innogate Pharma Co., LtdHangzhou Innogate Pharma Co., Ltd
10 Oct 2024
NeoplasmsDiscovery-
Hangzhou Innogate Pharma Co., LtdHangzhou Innogate Pharma Co., Ltd
10 Oct 2024
Nervous System DiseasesDiscovery-
Hangzhou Innogate Pharma Co., LtdHangzhou Innogate Pharma Co., Ltd
10 Oct 2024
Other DiseasesDiscovery-
Hangzhou Innogate Pharma Co., LtdHangzhou Innogate Pharma Co., Ltd
10 Oct 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free